Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 11M | $77M | 100% | Mar 2026 |
|
| Squadron Capital Management | 8.5M | $59M | 100% | Mar 2026 |
|
| VR Adviser | 4.8M | $34M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 4.8M | $33M | 12% | Mar 2026 |
|
| OrbiMed Advisors | 4.7M | $33M | 81% | Mar 2026 |
|
| Marshall Wace | 4.5M | $31M | 41% | Mar 2026 |
|
| Millennium Management | 3.9M | $27M | 134% | Mar 2026 |
|
| Vanguard Capital Management | 3.1M | $21M | 100% | Mar 2026 |
|
| RA Capital Management | 2.9M | $21M | 100% | Mar 2026 |
|
| Ikarian Capital | 2.7M | $19M | -12% | Mar 2026 |
|
| Driehaus Capital Management | 2.1M | $15M | 13% | Mar 2026 |
|
| Ameriprise Financial | 1.6M | $11M | -17% | Mar 2026 |
|
| Polar Capital Holdings | 1.4M | $9.8M | 100% | Mar 2026 |
|
| Susquehanna International | 1.3M | $9.3M | 209% | Mar 2026 |
|
| BlackRock | 1.3M | $9.0M | 2% | Mar 2026 |
|
| Sio Capital Management | 965k | $6.7M | 100% | Mar 2026 |
|
| Opaleye Management | 935k | $6.5M | 0% | Mar 2026 |
|
| Geode Capital Management | 849k | $5.9M | -1% | Mar 2026 |
|
| Soleus Capital Management | 842k | $5.9M | 100% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 842k | $5.9M | 100% | Mar 2026 |
|
| Eventide Asset Management | 842k | $5.9M | 100% | Mar 2026 |
|
| Boxer Capital Management | 842k | $5.9M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 729k | $5.1M | -13% | Mar 2026 |
|
| Goldman Sachs Group | 723k | $5.0M | 327% | Mar 2026 |
|
| CI Private Wealth | 720k | $5.0M | 0% | Mar 2026 |
|
| Acadian Asset Management | 713k | $5.0M | 35% | Mar 2026 |
|
| Qube Research & Technologies | 653k | $4.5M | 320% | Mar 2026 |
|
| Commodore Capital | 634k | $4.4M | 100% | Mar 2026 |
|
| Stempoint Capital | 597k | $4.2M | 100% | Mar 2026 |
|
| Point72 Asset Management | 505k | $3.5M | 169% | Mar 2026 |
|
| ADAR1 Capital Management | 452k | $3.1M | 1364% | Mar 2026 |
|
| Integral Health Asset Management | 450k | $3.1M | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 450k | $3.1M | 100% | Mar 2026 |
|
| Knott David M Jr | 439k | $3.1M | 100% | Mar 2026 |
|
| Woodline Partners | 421k | $2.9M | 100% | Mar 2026 |
|
| Birchview Capital | 409k | $2.8M | 100% | Mar 2026 |
|
| Two Sigma Investments | 408k | $2.8M | -29% | Mar 2026 |
|
| State Street Corporation | 357k | $2.5M | 11% | Mar 2026 |
|
| Parsons Capital Management | 353k | $2.5M | 34% | Mar 2026 |
|
| Jones Hill Capital | 343k | $2.4M | 100% | Mar 2026 |
|
| Seven Grand Managers | 316k | $2.2M | 100% | Mar 2026 |
|
| AdvisorShares Investments | 296k | $2.1M | -7% | Mar 2026 |
|
| Eversept Partners | 278k | $1.9M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 253k | $1.8M | -54% | Mar 2026 |
|
| Jane Street | 233k | $1.6M | -18% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 225k | $1.6M | 0% | Mar 2026 |
|
| Ally Bridge Group | 211k | $1.5M | 100% | Mar 2026 |
|
| Diadema Partners | 201k | $1.4M | -48% | Mar 2026 |
|
| Morgan Stanley | 199k | $1.4M | 218% | Mar 2026 |
|
| Renaissance Technologies | 167k | $1.2M | -10% | Mar 2026 |
|
| Sei Investments | 167k | $1.2M | 68% | Mar 2026 |
|
| Northern Trust | 158k | $1.1M | -5% | Mar 2026 |
|
| Eudaimonia Asset Management | 131k | $911k | -19% | Mar 2026 |
|
| UBS Group | 127k | $882k | 205% | Mar 2026 |
|
| Bank of America Corporation | 126k | $877k | 100% | Mar 2026 |
|
| Rbf Capital | 120k | $835k | -14% | Mar 2026 |
|
| Burkehill Global Management | 105k | $666k | 100% | Mar 2026 |
|
| We Are One Seven | 100k | $696k | 0% | Mar 2026 |
|
| Barclays | 89k | $619k | 48% | Mar 2026 |
|
| Brevan Howard Capital Management | 74k | $512k | 100% | Mar 2026 |
|
| Mangrove Partners | 72k | $499k | 162% | Mar 2026 |
|
| LMR Partners | 64k | $443k | 14% | Mar 2026 |
|
| Squarepoint Ops | 63k | $441k | -54% | Mar 2026 |
|
| Hillsdale Investment Management | 54k | $373k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 53k | $369k | 0% | Mar 2026 |
|
| Persistent Asset Partners | 51k | $353k | -78% | Mar 2026 |
|
| apricus wealth | 48k | $330k | 0% | Mar 2026 |
|
| Verdad Advisers | 47k | $328k | 100% | Mar 2026 |
|
| Fifth Lane Capital | 45k | $313k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 42k | $293k | 61% | Mar 2026 |
|
| OMERS Administration Corporation | 42k | $290k | -37% | Mar 2026 |
|
| Catalyst Funds Management Pty | 34k | $237k | 100% | Mar 2026 |
|
| XTX Topco | 34k | $234k | -19% | Mar 2026 |
|
| AlTi Global | 32k | $223k | 0% | Mar 2026 |
|
| Pale Fire Capital SE | 32k | $220k | -29% | Mar 2026 |
|
| Bank of Nova Scotia | 31k | $213k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 29k | $203k | 100% | Mar 2026 |
|
| Robertson Stephens Wealth Management | 25k | $174k | 0% | Mar 2026 |
|
| Citadel Advisors | 24k | $169k | -68% | Mar 2026 |
|
| Diametric Capital | 24k | $167k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 23k | $162k | 76% | Mar 2026 |
|
| Invesco | 22k | $156k | 100% | Mar 2026 |
|
| GSA Capital Partners | 20k | $136k | 100% | Mar 2026 |
|
| Leucadia National Corporation | 16k | $112k | -26% | Mar 2026 |
|
| Citigroup | 15k | $107k | 100% | Mar 2026 |
|
| Scientech Research | 15k | $102k | 100% | Mar 2026 |
|
| Group One Trading | 14k | $100k | 100% | Mar 2026 |
|
| Lido Advisors | 14k | $97k | 0% | Mar 2026 |
|
| Graham Capital Management | 14k | $94k | -47% | Mar 2026 |
|
| Keebeck Wealth Management | 13k | $91k | 100% | Mar 2026 |
|
| State of Wyoming | 13k | $88k | 100% | Mar 2026 |
|
| Quadrature Capital | 13k | $87k | -77% | Mar 2026 |
|
| Pensionmark Financial Group | 10k | $73k | 0% | Mar 2026 |
|
| Bedel Financial Consulting | 10k | $70k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 8.3k | $58k | 174% | Mar 2026 |
|
| Antipodes Partners | 3.0k | $21k | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 2.0k | $14k | 0% | Mar 2026 |
|
| American Capital Advisory | 2.0k | $14k | 0% | Mar 2026 |
|
| Massmutual Trust | 525.00 | $3.6k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 95.00 | $999.998500 | 100% | Mar 2026 |
|
| GAMMA Investing | 41.00 | $283.998800 | 100% | Jun 2026 |
|
| SBI Securities | 41.00 | $284.999200 | -28% | Mar 2026 |
|
| Caitong International Asset Management | 36.00 | $250.999200 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 5.00 | $34.000000 | 0% | Mar 2026 |
|
Who sold out of Relmada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Dec 2025 | 1.6M | $7.6M |
| Two Sigma Advisers | Dec 2025 | 162k | $783k |
| Seven Fleet Capital Management | Dec 2025 | 154k | $744k |
| Caption Management | Dec 2025 | 74k | $356k |
| ExodusPoint Capital Management | Dec 2025 | 69k | $333k |
| Simplex Trading | Dec 2025 | 19k | $90k |
| Virtu Financial | Dec 2025 | 18k | $85k |
| Lighthouse Investment Partners | Dec 2025 | 16k | $77k |
| Tortoise Investment Management | Dec 2025 | 14k | $67k |
| Farther Finance Advisors | Mar 2026 | 684.00 | $4.9k |